Related Experiment Videos
Multimodal treatment and prognostic factors in GI cancer--introduction
World Journal of Surgery
|March 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2005
[Abdomino-right-thoracic esophagectomy with intrathoracic anastomosis in Barrett's cancer].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2005
[Patient safety in view of specialization, minimum quantity and regionalization].
Deutsche medizinische Wochenschrift (1946)·2005
[Reoperation for thyroid cancer].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2005
[Barrett's esophagus].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2004
Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2004
Small Bowel Cancer: Implications of Preoperative Work-Up on Surgical Strategy.
World journal of surgery·2026
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026